5.74
Schlusskurs vom Vortag:
$5.62
Offen:
$5.54
24-Stunden-Volumen:
97,427
Relative Volume:
1.23
Marktkapitalisierung:
$38.68M
Einnahmen:
$15.27M
Nettoeinkommen (Verlust:
$-62.63M
KGV:
-0.7796
EPS:
-7.3629
Netto-Cashflow:
$-114.74M
1W Leistung:
+2.32%
1M Leistung:
+6.30%
6M Leistung:
+25.88%
1J Leistung:
-31.02%
Generation Bio Co Stock (GBIO) Company Profile
Firmenname
Generation Bio Co
Sektor
Branche
Telefon
857-529-5908
Adresse
301 BINNEY STREET, CAMBRIDGE
Compare GBIO vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
GBIO
Generation Bio Co
|
5.74 | 37.87M | 15.27M | -62.63M | -114.74M | -7.3629 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.81 | 119.38B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
766.63 | 81.46B | 14.34B | 4.50B | 3.88B | 41.57 |
|
ARGX
Argen X Se Adr
|
820.31 | 52.65B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.24 | 46.50B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
347.00 | 38.95B | 4.98B | 69.60M | 525.67M | 0.5198 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-16 | Herabstufung | Jefferies | Buy → Hold |
| 2025-12-16 | Hochstufung | Wedbush | Neutral → Outperform |
| 2025-08-13 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-10-19 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2022-11-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-12-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-06-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-02-24 | Eingeleitet | William Blair | Outperform |
| 2021-02-18 | Eingeleitet | Needham | Buy |
| 2020-07-07 | Eingeleitet | Cowen | Outperform |
| 2020-07-07 | Eingeleitet | JP Morgan | Overweight |
| 2020-07-07 | Eingeleitet | Jefferies | Buy |
| 2020-07-07 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Generation Bio Co Aktie (GBIO) Neueste Nachrichten
Buyout Rumor: How correlated is SQFTW to the S P5002025 Key Highlights & Community Consensus Trade Alerts - baoquankhu1.vn
Satellos Bioscience Welcomes New Chief Development Officer - GuruFocus
Satellos taps ex-Generation Bio COO to steer Duchenne trial plans - stocktitan.net
Returns Recap: How liquid is NCC.PRBC stockIPO Watch & Smart Money Movement Tracker - baoquankhu1.vn
S P Trends: Why is Generation Bio Co stock going down2025 AllTime Highs & Smart Investment Allocation Insights - baoquankhu1.vn
Halper Sadeh LLC Encourages DHIL, GBIO, CTGO Shareholders to Contact the Firm to Discuss Their Rights - Finviz
Halper Sadeh Investigates Shareholder Rights Violations at Diamond Hill, Generation Bio, and Contango - Intellectia AI
Investor Mood: Is Generation Bio Co a defensive stockTrade Entry Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Gap Down: Whats next for Generation Bio Co stockBreakout Watch & Long-Term Growth Plans - baoquankhu1.vn
Profit Review: Is Gen Digital Inc. in a long term uptrendEntry Point & Technical Pattern Based Signals - baoquankhu1.vn
Hedge Fund Moves: Is Generation Bio Co benefiting from innovation trendsWeekly Profit Report & Free Reliable Trade Execution Plans - baoquankhu1.vn
Growth Value: Is Generation Bio Co benefiting from innovation trendsTake Profit & Daily Chart Pattern Signals - baoquankhu1.vn
Retail Surge: Can Vivid Seats Inc expand into new marketsJuly 2025 Review & Risk Managed Trade Strategies - baoquankhu1.vn
Aug Levels: Can Generation Bio Co grow without external fundingWeekly Trend Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Halper Sadeh LLC Encourages CTGO, GBIO, CDE Shareholders to Contact the Firm to Discuss Their Rights - The Malaysian Reserve
Aug PostEarnings: Will Generation Bio Co outperform small cap indexesTrade Entry Summary & Daily Stock Trend Reports - baoquankhu1.vn
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—FFWM, CFLT, GBIO, and CTGO - GlobeNewswire Inc.
Generation Bio Co. (NASDAQ:GBIO) Receives Average Rating of “Hold” from Analysts - Defense World
Can Generation Bio Co. stock sustain institutional interestBear Alert & Free Community Consensus Stock Picks - ulpravda.ru
Can Generation Bio Co. stock sustain revenue growthJuly 2025 Update & Growth Focused Entry Reports - Улправда
Can Generation Bio Co. stock weather global recessionJuly 2025 Rallies & Free Weekly Watchlist of Top Performers - ulpravda.ru
Generation Bio (NASDAQ:GBIO) Stock Price Down 0.4% – Here’s What Happened - Defense World
What analysts say about Generation Bio Co stockMarket Sentiment Extremes & These Picks Are Just One Breakout Away - earlytimes.in
Generation Bio (GBIO) price target decreased by 70.88% to 9.01 - MSN
Deal Watch: Boehringer Signs On For Rectify’s Chronic Kidney Disease Assets - Citeline News & Insights
Jefferies downgrades Generation Bio (GBIO) - MSN
Generation Bio trading halted, news pending - MSN
Patterns Watch: Can Generation Bio Co stock sustain revenue growthTrade Analysis Report & Weekly Stock Performance Updates - moha.gov.vn
How Generation Bio Co. stock reacts to global recession fearsTrade Analysis Summary & Daily Entry Point Trade Alerts - Улправда
Brokerages Set Generation Bio Co. (NASDAQ:GBIO) PT at $9.25 - Defense World
Why Generation Bio Co. stock remains on buy listsEarnings Trend Report & Real-Time Volume Triggers - DonanımHaber
Why Generation Bio Co. stock is rated strong buyDividend Hike & Target Return Focused Picks - Улправда
Is Generation Bio Co. stock a safe buy before earningsJuly 2025 Chart Watch & Fast Gaining Stock Reports - Улправда
Retail Trends: Why Generation Bio Co. stock is rated strong buyJuly 2025 Volume & Long Hold Capital Preservation Tips - Улправда
Generation Bio stock rating reiterated at Market Perform by Citizens - Investing.com South Africa
Generation Bio trading resumes - MSN
Generation Bio announces merger with XOMA Royalty - MSN
Generation Bio stock rating reiterated at Market Perform by Citizens By Investing.com - Investing.com Canada
Generation Bio (NASDAQ:GBIO) Given a $5.50 Price Target at Wedbush - Defense World
Wedbush Upgrades Generation Bio (GBIO) - Nasdaq
Generation Bio (GBIO) Price Target Increased by 13.40% to 30.94 - MSN
Generation Bio (GBIO) Rating Update: Wedbush Upgrades to Outperf - GuruFocus
NodThera appoints Geoff McDonough, M.D., as independent board member - marketscreener.com
GBIO Downgraded by Jefferies with Price Target Cut by 54.55% | G - GuruFocus
‘Zombie’ biotech buyer Xoma to acquire Generation Bio - BioPharma Dive
Wedbush Upgrades Generation Bio to Outperform From Neutral, Adjusts Price Target to $5.50 From $7 - marketscreener.com
Jefferies Downgrades Generation Bio to Hold From Buy, Adjusts Price Target to $5 From $11 - marketscreener.com
Hold Rating on XOMA’s Acquisition of Generation Bio: Balancing Immediate Cash Offer with Potential Future Returns - TipRanks
Jefferies downgrades Generation Bio stock to Hold as XOMA acquisition announced - Investing.com Nigeria
XOMA Strikes Deal To Acquire Generation Bio, Expanding Royalty Portfolio - Nasdaq
XOMA to Acquire Generation Bio (GBIO) in Strategic Merger - GuruFocus
Finanzdaten der Generation Bio Co-Aktie (GBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):